Anschutz Cancer Pavilion-University of Colorado

Aurora, Colorado 80045

0 studies enrolling now · 4 studies all time

What they study most

Chronic Graft Versus Host Disease, Hematologic Malignancies, MPN (Myeloproliferative Neoplasms), Myelodysplastic Syndromes, Myelofibrosis, Postlung Transplant (Bronchiolitis Obliterans)

Studies at this site

• A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib — Stopped early
• GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease — Stopped early
• A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Participants With Myelofibrosis — Completed
• Oral Rigosertib in Low Risk MDS Patients Refractory to ESAs — Completed